KEY FEATURES
Full Name | Interleukin 11 |
---|---|
Synonym | AGIF; Adipogenesis Inhibitory Factor; Oprelvekin |
Assay Type | Sandwich |
Reactivity | Human |
Range | 15.6-1000pg/mL |
Sensitivity | 6pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human IL-11 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IL-11. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IL-11 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IL-11, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IL-11. You can calculate the concentration of Human IL-11 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human IL-11 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 55.34 | 114.14 | 388.83 | 54.64 | 122.08 | 371.07 |
Standard deviation | 3.62 | 5.81 | 20.14 | 3.33 | 6.7 | 15.07 |
CV(%) | 6.55 | 5.09 | 5.18 | 6.1 | 5.49 | 4.06 |
RECOVERY
The recovery of Human IL-11 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 90-105 | 97 |
EDTA plasma (n=8) | 90-102 | 97 |
Cell culture media (n=8) | 85-96 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human IL-11 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CLA ELISA Kits
CCR10 ELISA Kit | publications with CLA and CCR10 |
CCL20 ELISA Kit | publications with CLA and CCL20 |
CXCL10 ELISA Kit | publications with CLA and CXCL10 |
CCR7 ELISA Kit | publications with CLA and CCR7 |
CCL21 ELISA Kit | publications with CLA and CCL21 |
CCR6 ELISA Kit | publications with CLA and CCR6 |
CCR5 ELISA Kit | publications with CLA and CCR5 |
CCL25 ELISA Kit | publications with CLA and CCL25 |
CCBP2 ELISA Kit | publications with CLA and CCBP2 |
CXCR5 ELISA Kit | publications with CLA and CXCR5 |
Pathways associated with CLA ELISA Kit
Chemokine Receptors Bind Chemokines Pathway | Chemokine Receptors Bind Chemokines Pathway |
Chemokine Signaling Pathway | Chemokine Signaling Pathway |
Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
G Alpha (i) Signalling Events Pathway | G Alpha (i) Signalling Events Pathway |
GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
Peptide Ligand-binding Receptors Pathway | Peptide Ligand-binding Receptors Pathway |
Diseases associated with CLA ELISA Kit
Immune System Diseases | publications with CLA and Immune System Diseases |
Necrosis | publications with CLA and Necrosis |
Skin Neoplasms | publications with CLA and Skin Neoplasms |
Disease Models, Animal | publications with CLA and Disease Models, Animal |
Dermatitis, Allergic Contact | publications with CLA and Dermatitis, Allergic Contact |
Drug-Related Side Effects and Adverse Reactions | publications with CLA and Drug-Related Side Effects and Adverse Reactions |
Nervous System Diseases | publications with CLA and Nervous System Diseases |
Liver Diseases | publications with CLA and Liver Diseases |
Liver Neoplasms | publications with CLA and Liver Neoplasms |
Precancerous Conditions | publications with CLA and Precancerous Conditions |
Organs/Tissues associated with CLA ELISA Kit
Lung | publications with CLA and Lung |
Connective Tissue | publications with CLA and Connective Tissue |
Eye | publications with CLA and Eye |
Testis | publications with CLA and Testis |
Placenta | publications with CLA and Placenta |